Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 124 JPY -1.12% Market Closed
Market Cap: 32.5B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Daito Pharmaceutical Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daito Pharmaceutical Co Ltd
Cost of Revenue Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Cost of Revenue
-ÂĄ37.8B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
-4%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cost of Revenue
-ÂĄ1.5T
CAGR 3-Years
-14%
CAGR 5-Years
-13%
CAGR 10-Years
-12%
Daiichi Sankyo Co Ltd
TSE:4568
Cost of Revenue
-ÂĄ416.7B
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
Otsuka Holdings Co Ltd
TSE:4578
Cost of Revenue
-ÂĄ639.6B
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
-3%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cost of Revenue
-ÂĄ337.2B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
Astellas Pharma Inc
TSE:4503
Cost of Revenue
-ÂĄ383.6B
CAGR 3-Years
-16%
CAGR 5-Years
-6%
CAGR 10-Years
-2%

See Also

What is Daito Pharmaceutical Co Ltd's Cost of Revenue?
Cost of Revenue
-37.8B JPY

Based on the financial report for Aug 31, 2024, Daito Pharmaceutical Co Ltd's Cost of Revenue amounts to -37.8B JPY.

What is Daito Pharmaceutical Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-4%

Over the last year, the Cost of Revenue growth was -7%. The average annual Cost of Revenue growth rates for Daito Pharmaceutical Co Ltd have been -2% over the past three years , -2% over the past five years , and -4% over the past ten years .

Back to Top